Recall Register

Device recall: Access Total T3 Reagent, PN: 33830 The Access Total T3 assay is used for the quantitative determination of…

Class III FDA enforcement event 62791. Recall start date: . Status in the FDA record: Terminated. Termination date: .

Reason for recall, in the words of FDA

A recall was initiated because Beckman Coulter has identified a negative bias in test results when comparing elevated Total T3 patient samples diluted with Sample Diluent A to samples diluted with Access Total T3 Calibrator S0.

Class III, in the words of FDA

a situation in which use of or exposure to a violative product is not likely to cause adverse health consequences

Beckman Coulter Inc. started this device recall on 11 Oct 2011. The firm address in the FDA record is in Brea, CA. FDA put the recall in Class III. FDA event 62791 has 1 product record. The first FDA enforcement report date is 29 Aug 2012. The record gives the status Terminated, with the termination date 14 Mar 2013.

It is important to note that most of the time recall classifications are determined after the recalling firm provides all of the information needed to determine the risk posed to public health. The classification and posting in the FDA Enforcement Report should not be seen as an expansion or change to a firm’s voluntary public warning.

FDA publishes these words. Source: FDA, Enforcement Reports, Important Note, read on . openFDA export of .

Distribution

In the words of FDA.

Worldwide Distribution - USA (nationwide), Canada, and internationally.

Recalling firm

Beckman Coulter Inc., Brea, CA.

Recalling firm: The firm that the FDA record names for a recall.

FDA records how the recall started: Voluntary: Firm initiated.

Products

1 product record in the event.

FDA event 62791: product records
Recall numberProductQuantityClassStatusReport date
Z-2227-2012Access Total T3 Reagent, PN: 33830 The Access Total T3 assay is used for the quantitative determination of triiodothyronine (T3) levels in human serum and plasma in the assessment of thyroid function and diagnosis of thyroid disorders when T3 levels are between 0.1 and 8.0 ng/mL.117,385 units total (33,918 units in US)Class IIITerminated29 Aug 2012

openFDA, about the status: FDA does not update the status of a recall after the recall has been classified according to its level of hazard. As such, the status of a recall (open, completed, or terminated) will remain unchanged after published in the Enforcement Reports. Source: openFDA, Drug Recall Enforcement Reports, Disclaimer.

Enforcement report: The FDA publication that lists recalls. It has one record for each product of a recall.

Enforcement event: All the product records that have one FDA event number. This site shows one event on one page.

Class III: The lowest of the three FDA recall classes.

The event in context

Device events that started in 2011
114
Share of these events in Class III
7%
Product records in this event
1Median of the firm: 1
Events of the firm on the register
216

Other events of the firm

Official channels

Cite this page

Recall Register. FDA enforcement event 62791. https://recallregister.com/fda/iii/62791/. Source: openFDA enforcement reports. Data through .

Sources

Source
openFDA device enforcement reports
Licence
CC0 1.0
Export date
28 Sep 2026
Newest FDA report date on the register
23 Sep 2026

FDA has one record for each product. This site puts the records with the same event number on one page. The class of the event is the highest class of its records. How the register is made. Report an error.

Questions

Where was the product distributed?
The FDA record gives this distribution: Worldwide Distribution - USA (nationwide), Canada, and internationally.
What quantity of product is in FDA event 62791?
The FDA record gives this quantity: 117,385 units total (33,918 units in US)
How did the recall start?
The FDA record says: Voluntary: Firm initiated
How many device recalls of 2011 have the same class?
7% of the 114 device events that started in 2011 are in Class III.